-
In Vitro Interactions between Apricitabine and Other Deoxycytidine
Analogues.
Bethell R, De Muys J, Lippens J. et al
Antimicrob Agents Chemother.
2007 Aug;51(8):2948-53.
Abstract
- FULL-TEXT
ARTICLE
In vitro antiretroviral activity and in vitro toxicity profile of
SPD754, a new deoxycytidine
nucleoside reverse
transcriptase inhibitor for treatment of human immunodeficiency virus
infection.
Gu Z, Allard B, de Muys JM,et al
Antimicrob Agents Chemother. 2006 Feb;50(2):625-31
Paper
-
In vitro activity of SPD754, a new deoxycytidine nucleoside reverse
transcriptase inhibitor (NRTI),
against 215 HIV-1 isolates resistant to other NRTIs.
Bethell RC, Lie YS, Parkin NT.
Antivir Chem Chemother. 2005;16(5):295-302.
Abstract
|
-
A WEEK-IN-REVIEW FEATURED REPORT
Comparison of the pharmacokinetics of apricitabine in the presence and
absence of
ritonavir-boosted tipranavir: a phase I, open-label, controlled,
single-centre study.
Cox S, Southby J, Linet O, et al
Clin Drug Investig.
2009;29(11):721-8.
Abstract -
Influence of food on the pharmacokinetics of apricitabine, a novel
deoxycytidine analogue
reverse transcriptase inhibitor.
Holdich T, Sawyer J.
Expert
Opin Pharmacother. 2008 Aug;9(12):2021-5
Abstract -
Pharmacokinetics of apricitabine, a novel nucleoside
reverse transcriptase inhibitor, in healthy
volunteers treated with trimethoprim-sulphamethoxazole.
Shiveley L, Struthers-Semple C, Cox S, Sawyer J.
J Clin Pharm Ther.
2008 Feb;33(1):45-54.
Abstract -
A WEEK-IN-REVIEW FEATURED REPORT
Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside
Reverse Transcriptase
Inhibitor, in Patients with HIV-1 Infection.
Cahn P, Rolon M, Cassetti I, et al
Clin Drug Investig. 2008;28(2):129-38.
Abstract -
Effect of lamivudine on the plasma and
intracellular pharmacokinetics of apricitabine, a novel
nucleoside reverse transcriptase inhibitor, in healthy
volunteers.
Holdich T, Shiveley LA, Sawyer J.
Antimicrob Agents Chemother. 2007 Jan 22;
Abstract-
Pharmacokinetics of single oral doses of apricitabine, a novel
deoxycytidine analogue reverse
transcriptase inhibitor, in healthy volunteers.
Holdich T, Shiveley L, Sawyer J.
Clin Drug Investig. 2006;26(5):279-86.
Abstract
|
|
General
Reports
Apricitabine
Main Page
Main New
and Noteworthy
Documents
identified with this icon are in Portable Document Format (PDF) and require the
